1265 related articles for article (PubMed ID: 32842246)
21. Impact of inguinal dissection on prognosis of early-stage squamous cell carcinoma of the vulva--a retrospective analysis.
Kouvaris JR; Kouloulias VE; Kondi-Pahpiti A; Kokakis JD; Vlahos LJ
Onkologie; 2003 Dec; 26(6):564-7. PubMed ID: 14709931
[TBL] [Abstract][Full Text] [Related]
22. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block.
Dusenbery KE; Carlson JW; LaPorte RM; Unger JA; Goswitz JJ; Roback DM; Fowler JM; Adcock LL; Carson LF; Potish RA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):989-98. PubMed ID: 8083101
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.
Zapardiel I; Gracia M; Díez J; Buda A; Noya MC; Iaco P; Vieira-Baptista P; Iacoponi S;
Arch Gynecol Obstet; 2021 Mar; 303(3):759-766. PubMed ID: 33067709
[TBL] [Abstract][Full Text] [Related]
24. Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
Wohlmuth C; Wohlmuth-Wieser I; May T; Vicus D; Gien LT; Laframboise S
Am J Clin Dermatol; 2020 Apr; 21(2):285-295. PubMed ID: 31784896
[TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
Scheistrøen M; Tropé C; Koern J; Pettersen EO; Abeler VM; Kristensen GB
Cancer; 1995 Jan; 75(1):72-80. PubMed ID: 7804980
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of lymph node ratio and number of positive inguinal nodes in patients with vulvar cancer.
Polterauer S; Schwameis R; Grimm C; Macuks R; Iacoponi S; Zalewski K; Zapardiel I;
Gynecol Oncol; 2017 Oct; 147(1):92-97. PubMed ID: 28797698
[TBL] [Abstract][Full Text] [Related]
27. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.
Siller BS; Alvarez RD; Conner WD; McCullough CH; Kilgore LC; Partridge EE; Austin JM
Gynecol Oncol; 1995 Jun; 57(3):335-9. PubMed ID: 7774837
[TBL] [Abstract][Full Text] [Related]
28. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.
van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC
Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136
[TBL] [Abstract][Full Text] [Related]
29. Prognostic analysis of early-stage squamous cell carcinoma of the vulva.
Xu LQ; Luo RZ; Sun XM; He JH; Zhang YN
World J Surg Oncol; 2013 Jan; 11():20. PubMed ID: 23351240
[TBL] [Abstract][Full Text] [Related]
30. Vulvar cancer: surgical management and survival trends in a low resource setting.
Kumar N; Ray MD; Sharma DN; Pandey R; Lata K; Mishra A; Wankhede D; Saikia J
J Egypt Natl Canc Inst; 2020 Jan; 32(1):4. PubMed ID: 32372283
[TBL] [Abstract][Full Text] [Related]
31. Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial.
Höckel M; Trott S; Dornhöfer N; Horn LC; Hentschel B; Wolf B
Lancet Oncol; 2018 Apr; 19(4):537-548. PubMed ID: 29530664
[TBL] [Abstract][Full Text] [Related]
32. Management of vulvar melanoma.
Trimble EL; Lewis JL; Williams LL; Curtin JP; Chapman D; Woodruff JM; Rubin SC; Hoskins WJ
Gynecol Oncol; 1992 Jun; 45(3):254-8. PubMed ID: 1612500
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
Bokhman JV; Maximov SJ; Ebert AD
Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
[TBL] [Abstract][Full Text] [Related]
34. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience.
Zhu J; Yin L; Wang Q; Wu X; Ke G
Int J Clin Oncol; 2020 Dec; 25(12):2144-2150. PubMed ID: 32779039
[TBL] [Abstract][Full Text] [Related]
36. Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation?
Manavi M; Berger A; Kucera E; Vavra N; Kucera H
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):749-53. PubMed ID: 9240642
[TBL] [Abstract][Full Text] [Related]
37. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
[TBL] [Abstract][Full Text] [Related]
38. No. 370-Management of Squamous Cell Cancer of the Vulva.
Francis JA; Eiriksson L; Dean E; Sebastianelli A; Bahoric B; Salvador S
J Obstet Gynaecol Can; 2019 Jan; 41(1):89-101. PubMed ID: 30580832
[TBL] [Abstract][Full Text] [Related]
39. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?
Thaker NG; Klopp AH; Jhingran A; Frumovitz M; Iyer RB; Eifel PJ
Gynecol Oncol; 2015 Feb; 136(2):269-73. PubMed ID: 25524458
[TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
